<DOC>
	<DOCNO>NCT01298609</DOCNO>
	<brief_summary>The study design prospective , randomize , double-blind , single center study 6 month duration post permanent system implantation . Forty patient implanted . During trial stimulation , patient randomize one two study arm two week . Crossover occur 2 week study visit opposite group . After completion two arm , every patient subsequently complete participation third study arm . After completion third arm , patient evaluate determine positive responder responder . If , patient option obtain permanent implant .</brief_summary>
	<brief_title>Occipital Nerve ( C2 ) Stimulation Treatment Fibromyalgia</brief_title>
	<detailed_description />
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<criteria>1 . Patients able provide inform consent participate study ; 2 . Patient chronic widespread pain least 3 month 4 body quadrant ; 3 . Patient least 11 18 tender point base tender point examination ; 4 . Patient attempt `` best '' medical therapy try fail least three document medically supervised treatment ( include , limited drug , physical therapy , acupuncture , etc . ) ; 5 . Patient medication remain stable least 4 week prior baseline data collection ; 6 . Psychological screening complete patient cleared psychologist suitable study candidate ; 7 . Patient agree add increase medication throughout randomization trial period study ; 8 . Patient willing cooperate study requirement include compliance treatment regimen completion office visit . 1 . Patient current evidence psychiatric disorder , document DSMIVTR criterion psychotic characteristic , ( e.g . bipolar disorder , major depressive disorder ) ; 2 . Patient diagnose disease mimicking symptom Fibromyalgia Syndrome ( e.g . Epstein Barr , autoimmune disease , etc . ) currently treat stable least 6 month ; 3 . Patient currently active menopause ; 4 . Patient diagnose sleep apnea currently involve treatment regime ; 5 . Patient history substance abuse substance dependency past 6 month prior baseline data collection ; 6 . Patient currently participate another clinical study ; 7 . Patient demandtype cardiac pacemaker , infusion pump implantable neurostimulator device ; 8 . Patient likely require MRI evaluation future ; 9 . Patient willing maintain current medication regimen ; 10 . Female candidate child bear potential pregnant ( confirm positive urine/blood pregnancy test ) , use adequate contraception determine investigator , nursing ( lactate ) child .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Fibromyalgia</keyword>
	<keyword>Occipital Nerve Stimulation</keyword>
</DOC>